Private Advisor Group, LLC Vbi Vaccines Inc Transaction History

Private Advisor Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.29 - $0.64 $26 - $57	90 Added 0.34%	26,390 $7,000
Q3 2022 Oct 14, 2022	SELL	$0.73 - $23.4 $193 - $6,201	-265 Reduced 1.0%	26,300 $19,000
Q2 2022 Jul 13, 2022	SELL	$0.66 - $1.81 $4,620 - $12,670	-7,000 Reduced 20.86%	26,565 $21,000
Q4 2021 Feb 10, 2022	BUY	$2.21 - $3.22 $2,210 - $3,220	1,000 Added 3.07%	33,565 $79,000
Q3 2021 Oct 14, 2021	SELL	$2.8 - $3.72 $4,200 - $5,580	-1,500 Reduced 4.4%	32,565 $101,000
Q2 2021 Aug 12, 2021	SELL	$2.61 - $4.17 $15,098 - $24,123	-5,785 Reduced 14.52%	34,065 $114,000
Q1 2021 Apr 22, 2021	BUY	$2.91 - $4.32 $8,002 - $11,880	2,750 Added 7.41%	39,850 $124,000
Q4 2020 Apr 01, 2021	BUY	$2.15 - $3.5 $4,622 - $7,525	2,150 Added 6.15%	37,100 $102,000
Q3 2020 Nov 02, 2020	BUY	$2.77 - $6.17 $38,087 - $84,837	13,750 Added 64.86%	34,950 $100,000
Q2 2020 Aug 17, 2020	BUY	$0.87 - $3.13 $18,444 - $66,356	21,200 New	21,200 $66,000
Q4 2019 Feb 10, 2020	SELL	$0.48 - $1.38 $5,280 - $15,179	-11,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.47 - $1.05 $5,170 - $11,550	11,000 New	11,000 $5,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.